Ischemic and Bleeding Events in PENDULUM Patients With High Bleeding Risk and High Platelet Reactivity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ischemic and Bleeding Events in PENDULUM Patients With High Bleeding Risk and High Platelet Reactivity

Published:2021-12-08 Issue: Volume: Page:
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Iijima Raisuke¹,Kadota Kazushige²,Nakao Koichi³,Nakagawa Yoshihisa⁴,Shite Junya⁵,Yokoi Hiroyoshi⁶,Kozuma Ken⁷,Tanabe Kengo⁸,Akasaka Takashi⁹,Shinke Toshiro¹⁰,Ueno Takafumi¹¹,Hirayama Atsushi¹²,Uemura Shiro¹³,Harada Atsushi¹⁴,Kuroda Takeshi¹⁵,Takita Atsushi¹⁶,Murakami Yoshitaka¹⁷,Saito Shigeru¹⁸,Nakamura Masato¹

Affiliation:

1. Division of Cardiovascular Medicine, Toho University Ohashi Medical Center

2. Department of Cardiology, Kurashiki Central Hospital

3. Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center

4. Department of Cardiovascular Medicine, Shiga University of Medical Science

5. Division of Cardiology, Osaka Saiseikai Nakatsu Hospital

6. Cardiovascular Medicine Center, Fukuoka Sanno Hospital

7. Division of Cardiology, Department of Internal Medicine, Teikyo University

8. Division of Cardiology, Mitsui Memorial Hospital

9. Department of Cardiovascular Medicine, Wakayama Medical University

10. Division of Cardiology, Department of Medicine, Showa University School of Medicine

11. Department of Cardiovascular Medicine, Fukuoka Kinen Hospital

12. Department of Cardiology, Osaka Police Hospital

13. Department of Cardiology, Kawasaki Medical School

14. Medical Information Department, Daiichi Sankyo Co., Ltd.

15. Primary Medical Science Department, Daiichi Sankyo Co., Ltd.

16. Data Intelligence Department, Daiichi Sankyo Co., Ltd.

17. Department of Medical Statistics, School of Medicine, Toho University

18. Division of Cardiology & Catheterization Laboratories, Shonan Kamakura General Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-21-0717/_pdf

Reference32 articles.

1. 1. Moon JY, Franchi F, Rollini F, Angiolillo DJ. Evolution of coronary stent technology and implications for duration of dual antiplatelet therapy. Prog Cardiovasc Dis 2018; 60: 478–490.

2. 2. Mangieri A, Gallo F, Sticchi A, Khokhar AA, Laricchia A, Giannini F, et al. Dual antiplatelet therapy in coronary artery disease: From the past to the future prospective. Cardiovasc Interv Ther 2020; 35: 117–129.

3. 3. Iijima R, Nakamura M. Optimal revascularization strategy for acute coronary syndromes with high bleeding risk: It is hard to please all parties. Circ J 2021; 85: 1942–1943.

4. 4. Esmonde S, Sharma D, Peace A. Antiplatelet agents in uncertain clinical scenarios: A bleeding nightmare. Cardiovasc Diagn Ther 2018; 8: 647–662.

5. 5. Saito Y, Kobayashi Y. Contemporary coronary drug-eluting and coated stents: A mini-review. Cardiovasc Interv Ther 2021; 36: 20–22.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of CYP2C19 genotype polymorphism and clopidogrel resistance on ischemic event occurrence in patients with peripheral arterial disease undergoing revascularization: A prospective cohort study;Thrombosis Research;2024-04

2. Thrombocytopenia as a Bleeding Risk Factor in Atrial Fibrillation and Coronary Artery Disease: Insights From the AFIRE Study;Journal of the American Heart Association;2023-10-17

3. Clinical characteristics and outcomes of patients with chronic systemic inflammatory disease in acute myocardial infarction;PLOS ONE;2023-08-24

4. Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN);Circulation Journal;2023-05-25

5. Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk　― Never Judge a Book by Its Cover ―;Circulation Journal;2023-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3